Brought to you by 
Bioglan, Winston Labs in pain management alliance
08 Mar 2001
Executive Summary
Bioglan (pharmaceuticals, dermatology, drug delivery, imaging, generics) and privately held Winston Laboratories (discovery and development of pain management therapies) have entered into a cross-licensing agreement in the field of pain management, a relatively new field for Bioglan.
Deal Industry
-
Pharmaceuticals
-
Drug Delivery
- Topical Delivery
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Marketing (Licensing)
- Product or Technology Swap
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Bioglan, Winston Labs in pain management alliance
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice